Fabry Disease Drug Market Size, Share, Global Industry Report and Top Manufactures- Sanofi, Takeda Pharmaceutical, Amicus Therapeutics, Moderna, JCR Pharmaceuticals Co, Novartis AG, Pfizer
Global Fabry Disease Drug Market Definition: Fabry disease is a rare genetic disorder caused by deficient activity of lysosomal enzyme called ?-galactosidase A (?-Gal A) which results in dysfunction of glycosphingolipid (fat) metabolism. Lysosomal enzyme is responsible for break down complex sugar-lipid molecules called glycolipids or digests particular compounds. The deficient of this enzyme may results in cell abnormalities and organ system dysfunction which will affects particularly small blood vessels, the heart and kidneys.
View full press release